Slán NYC

Directions Website

Menopause Management, Metabolic Management, Healthy Aging,
Libido Support for Men & Women, Gynecology & Longevity

11/09/2026

Menopause is SO much more than hot flashes.

A new study published in JCI Insight confirms something important: insulin resistance can accelerate during the menopause transition — even without significant weight changes.

Researchers followed more than 1,300 women and found that insulin resistance increased most rapidly during a four-year window surrounding their final menstrual period.

Why does this happen?

Declining estrogen and changes in body fat distribution, including increased visceral fat, may contribute to metabolic changes that aren’t always reflected on the scale.

Here’s the takeaway: Your weight doesn’t tell the whole story about your metabolic health.

Menopause is a major physiological transition, and understanding what’s happening inside your body matters.

At Slán NYC, we look beyond symptoms to evaluate metabolic health, identify risks, and develop personalized treatment plans.

🩵 You have options. Let’s talk about them.

11/05/2026

New here? Welcome. 💙 I’m Dr. McBride, and this is Slán, a place for women and men who want real answers, real time, and a plan built around their lives. Swipe to see how we work. Follow along for myth-busting, menopause and hormone health, and everything in between.

10/23/2026

We need to do better for women in menopause. Period.

A new Gallup survey reveals just how significant the gaps in menopause education and care really are.

Menopause is inevitable. Suffering without answers shouldn’t be.

At Slán NYC, we’re working to change that conversation — one woman at a time.

10/21/2026

To every woman who has ever felt frustrated, exhausted, or completely ignored by standard weight loss advice during midlife: this new data is for you.

As a medical professional, I see so many patients blame themselves for weight changes during menopause. But your biology is incredibly complex, and dropping estrogen levels drastically alter how your body stores energy.

The latest data from Novo Nordisk’s Phase 3 REDEFINE 1 trial is a massive step forward. It studied an investigational treatment called CagriSema (a combination of semaglutide and cagrilintide) and found that women achieved a 25% average weight loss—regardless of what stage of the menopause transition they were in.

This isn’t just a number on a scale; it validates that midlife metabolic shifts are real, and science is finally catching up to support you. The FDA is expected to make a decision on this treatment by the end of 2026.

If you’ve been struggling through this transition, please know you aren’t alone. How has your wellness journey shifted during menopause? Let’s talk in the comments. 👇

10/19/2026

Your smartwatch can track your sleep, heart rate, temperature, and recovery. But can it actually help you navigate menopause? 🤔

Apple, Oura, and WHOOP have introduced menopause-related features, but a recent New York Times article highlights some important limitations.

⌚ Apple: Relies on self-reported cycle data to flag possible perimenopause.

💍 Oura: Combines symptom questionnaires with sleep and temperature trends, but cannot determine whether you’re in perimenopause.

📊 WHOOP: Tracks self-reported symptoms like fatigue, brain fog, and mood changes, but its symptom-prediction feature doesn’t currently include hot flashes or night sweats.

These tools can help identify patterns, but they can’t diagnose menopause or explain what’s causing your symptoms.

The technology is promising. We’re just not there yet.

Your data can be helpful. But it can’t replace an experienced menopause specialist.

At Slán NYC, we look beyond the numbers to understand the whole picture.

10/13/2026

More hair on your chin. Less on your head. Menopause has a strange sense of humor. 😊

As estrogen declines, the balance between estrogen and androgens shifts. That can make facial hairs thicker and more noticeable—even without a rise in androgen levels.

Meanwhile, some women also experience scalp thinning. Different follicles, different responses. Oh joy.

If you’ve noticed those persistent chin hairs, you’re in good company. These changes are common, and you deserve answers about what’s happening and what can help.

09/30/2026

One of the most common questions I hear is:
“When do I have to get off hormone therapy?”

And the next one is:
“Is it too late to start?”

The answer is more individualized than many women were told.

The old blanket rule — “lowest dose for the shortest time” — has been replaced by a more nuanced approach: the right plan depends on your symptoms, age, menopause timing, medical history, risk factors, goals, and ongoing risk-benefit assessment.

The Menopause Society states that there is no general rule for stopping hormone therapy based on age alone, and that continuing beyond age 65 may be reasonable for some healthy women with persistent symptoms, with appropriate counseling and regular reassessment. (The Menopause Society)

Starting later is a different conversation. For many women, the benefit-risk profile is most favorable when hormone therapy is started before age 60 or within 10 years of menopause onset — but that does not mean every woman outside that window is automatically excluded. (The Menopause Society)

The key is individualized care.

Hormone therapy is not one-size-fits-all, and it is not risk-free. But women deserve expert guidance — not outdated rules, fear, or blanket dismissal.

09/28/2026

You may be hearing more about vision loss and GLP-1 medications — so let’s clarify the risk.

The condition being discussed is NAION, or non-arteritic anterior ischemic optic neuropathy. It is a rare condition involving reduced blood flow to the optic nerve that can cause sudden vision loss.

Recent observational studies have reported a modest but consistent association between semaglutide and increased NAION risk. One large 2025 JAMA Ophthalmology cohort study found further evidence of an association, but also found a smaller risk than earlier reports — and emphasized that more research is needed to understand mechanism and causality.

That distinction matters.

Diabetes and obesity are both risk factors for NAION, and many people taking GLP-1 medications have one or both. So the key question remains: is the risk from the medication, the underlying condition, rapid metabolic changes, or some combination?

We do not know yet.

The current evidence is observational, mixed, and not enough to prove causality. A 2025 meta-analysis found no significant increase in NAION or ischemic optic neuropathy risk when comparing semaglutide or GLP-1 users with diabetes or high-BMI controls. (pubmed.ncbi.nlm.nih.gov)

So this is not a reason to panic — but it is a reason to be informed.

If you are taking a GLP-1 medication, it should be prescribed and monitored by a qualified clinician. And if you experience sudden vision loss, darkening, blurring, or a curtain-like change in vision, seek urgent medical care immediately.

09/23/2026

Hashimoto’s thyroiditis can be tricky — especially in midlife.

It is the most common cause of hypothyroidism in iodine-sufficient areas, including the United States, and it occurs more often in women. It is an autoimmune condition, meaning the immune system attacks the thyroid gland over time. (Endocrine Society⁠)

The frustrating part? Symptoms can overlap with perimenopause and menopause:

Fatigue.
Brain fog.
Poor sleep.
Weight changes.
Joint pain.
Mood changes.
Feeling like something is “off.”

And sometimes women are told, “Your thyroid is normal,” even when they still feel unwell.

A proper evaluation may include more than a basic TSH. Depending on symptoms and history, your clinician may consider free T4, free T3 when appropriate, and thyroid-specific antibodies — especially thyroid peroxidase antibodies, which are commonly present in Hashimoto’s.

This does not mean every symptom is thyroid-related. It means women deserve a thoughtful workup that looks at the full picture: thyroid, hormones, metabolism, inflammation, sleep, stress, and menopause stage.

If you don’t feel like yourself, keep asking questions.

09/21/2026

Harry taught a generation to treat people with kindness. We just took it to the exam room. 🩵

Address

54 W 21st Street
New York, NY
10010

Website

http://slannyc.com/

Alerts

Be the first to know and let us send you an email when Slán NYC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.